414
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

, , , , , , & show all
Pages 1-19 | Published online: 17 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ashley Hedges, Matthew C. Findlay, Gary E. Davis, Brianne M. Wolfe, Gregory W.J. Hawryluk, Sarah T. Menacho & Safdar Ansari. (2023) Levetiracetam dosing for seizure prophylaxis in neurocritical care patients. Brain Injury 37:10, pages 1167-1172.
Read now

Articles from other publishers (10)

Sanjeev Kharel, Rajeev Ojha & Surendra Khanal. (2022) Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis. Brain and Behavior 12:11.
Crossref
Itzel Jatziri Contreras-García, Noemí Cárdenas-Rodríguez, Antonio Romo-Mancillas, Cindy Bandala, Sergio R. Zamudio, Saúl Gómez-Manzo, Beatriz Hernández-Ochoa, Julieta Griselda Mendoza-Torreblanca & Luz Adriana Pichardo-Macías. (2022) Levetiracetam Mechanisms of Action: From Molecules to Systems. Pharmaceuticals 15:4, pages 475.
Crossref
Marwa I. Hegazy I. Hegazy, Aman M. Asaad, Lila A. Rashed & Hanaa H. Ahmed. (2022) Combined Treatment of Levetiracetam and Mesenchymal Stem Cells Reverses the Biochemical Aberrations in the Acute Phase of Epilepsy Induced by Pilocarpine in Rats. Biomedical and Pharmacology Journal 15:1, pages 91-115.
Crossref
Gajanan Panchal, Salil UppalShikhil Uppal. (2022) Recent updates on Levetiracetam. IP Indian Journal of Neurosciences 8:1, pages 21-30.
Crossref
Iva Mikulić, Robert Likić & Slobodan M. Janković. (2022) Cost-Effectiveness of Zonisamide Versus Levetiracetam in Newly Diagnosed Focal Onset Epilepsy in Serbia. Value in Health Regional Issues 27, pages 49-57.
Crossref
Xiaodong Sun, Maryam Keywanlu & Reza Tayebee. (2021) Experimental and molecular dynamics simulation study on the delivery of some common drugs by ZIF‐67, ZIF‐90, and ZIF‐8 zeolitic imidazolate frameworks. Applied Organometallic Chemistry 35:11.
Crossref
Pim B. Meer, Linda Dirven, Marta Fiocco, Maaike J. Vos, Mathilde C. M. Kouwenhoven, Martin J. Bent, Martin J. B. Taphoorn & Johan A. F. Koekkoek. (2021) First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid. Epilepsia 62:5, pages 1119-1129.
Crossref
Zhan-Miao Yi, Xu-Li Zhong, Ming-Lu Wang, Yuan Zhang & Suo-Di Zhai. (2020) Efficacy, Safety, and Economics of Intravenous Levetiracetam for Status Epilepticus: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 11.
Crossref
Nasim Tabrizi, Ashraf Zarvani, Parisa Rezaei, Hamed Cheraghmakani & Reza Alizadeh-Navaei. (2019) Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial. Epilepsy Research 157, pages 106214.
Crossref
Francesca Felicia Operto, Grazia Maria Giovanna Pastorino, Roberta Mazza, Michele Roccella, Marco Carotenuto, Lucia Margari & Alberto Verrotti. (2019) Cognitive profile in BECTS treated with levetiracetam: A 2-year follow-up. Epilepsy & Behavior 97, pages 187-191.
Crossref